Innovation Pharmaceuticals Inc (IPIX)

[bradfordbros]

I really don't think you know what you are talking about.

Happy Thanksgiving



in answer to:


Who knows.

Phase 1 Solid Tumor results is the hopeful nearterm catalyst. We'd like to see some enormous efficacy in nonoptimized dosages against a variety of tumors if possible. Otherwise, it's just safe and we'll have to move forward with phase 2 trials. It seems to be doing a good job in the mice though.

Maybe an orphan designation for Pancreatic.
Phase 2 Ovarian with Docetaxel.
Phase 2 AML at UoB (pending funding)

I think Prurisol and Brilacidin are going to be the more exciting ones over the next year.